BPA Call 36E79718A0010-36C26020F0220
Award Date 2/7/20
Potential Completion Date 2/6/21
Potential Value $204K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Durham, NC 27709, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs Veterans Health Administration awarded Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals, a $130,406.43 delivery order contract for PROLASTIN 1000MG/VIAL. The contract is a firm fixed price agreement issued under the Pharmaceuticals and Drugs GSA Schedule. This award does not utilize a small business set-aside. Grifols has previously provided pharmaceutical products such as Prolastin, Prolastin-C, and...
- The Department of Veterans Affairs Veterans Health Administration awarded a delivery order contract to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals, for the provision of the drug PROLASTIN. The $202,942.32 firm fixed price contract is a delivery order issued under Grifols' Pharmaceuticals and Drugs GSA Schedule contract. The contract does not utilize any small business set-asides and has a performance period ending on April 15,...
- This federal contract award is for a Blanket Purchase Agreement (BPA) call from the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 7 to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract is for the delivery of Prolastin, a pharmaceutical product, with a potential value of $125,209.92. The contract does not utilize any small business set-asides and is a Firm Fixed...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm-fixed-price delivery order to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals, for the provision of the drug PROLASTIN. The $114,000.00 order was placed against Grifols' contract under the General Services Administration (GSA) Pharmaceuticals and Drugs (FSS-61-IB) schedule. This award did not utilize any small business set-asides. Grifols has previously...
- This is a $93,183.36 firm fixed price Blanket Purchase Agreement (BPA) call contract awarded by the U.S. Department of Veterans Affairs to Grifols Therapeutics LLC, a manufacturer of pharmaceuticals and biopharmaceuticals. The contract is for the provision of the pharmaceutical product Prolastin to the Veterans Integrated Service Network 7 for the 2018 fiscal year. The contract was awarded on March 29, 2018 and has an ultimate completion date of September 30, 2018. This contract was not set...
- This is a Firm Fixed Price Blanket Purchase Agreement (BPA) call order awarded by the Department of Veterans Affairs (VA) to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract is for the delivery of PROLASTIN-C, a pharmaceutical product, with a ceiling value of $214,014.72 and a period of performance through September 30, 2016. The contract is issued under the Pharmaceuticals and Drugs GSA Schedule vehicle and does not utilize...
- This is a federal contract award for the pharmaceutical product Prolastin, awarded by the Department of Veterans Affairs (VA) to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract is a delivery order under the Pharmaceuticals and Drugs General Services Administration (GSA) Schedule, with a firm fixed price and a ceiling value of $162,548.16. This award does not utilize any small business set-asides. Grifols Therapeutics LLC...
- This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract is for the supply of PROLASTIN-C PHARMACEUTICALS and is issued under the VA's Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB). The contract has a ceiling value of $94,800.00 and a period of performance ending on September 30, 2015. The contract does not utilize any small...
- This is a Fiscal Year 2019 bulk funding order for Prolastin, a pharmaceutical product, awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract is a Blanket Purchase Agreement (BPA) call against the Pharmaceuticals and Drugs GSA Schedule. The contract has a potential value of $193,787.52 and a completion date of September 30, 2019. No small business...
- This federal contract award to Grifols USA LLC, a global healthcare company, is for the pharmaceutical product PROLASTIN-C LIQUID. The contract, valued at $11,502.40, is a delivery order awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 5 (VISN 5). PROLASTIN-C is an alpha1-proteinase inhibitor used to treat alpha1-antitrypsin deficiency. The contract has a firm fixed price and an ultimate completion date of August 23, 2024. Grifols USA LLC holds a Federal...